Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018

Jeffrey Hung Maintained (VYGR) at Buy with Increased Target to $39 on, Feb 21st, 2018

Jeffrey Hung of Morgan Stanley, Maintained "Voyager Therapeutics, Inc." (VYGR) at Buy with Increased Target from $36 to $39 on, Feb 21st, 2018.

Jeffrey has made no other calls on VYGR in the last 4 months.



There are 3 other peers that have a rating on VYGR. Out of the 3 peers that are also analyzing VYGR, 0 agree with Jeffrey's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Jeffrey


  • Dane Leone of "BTIG" Initiated at Strong Buy and Held Target at $32 on, Wednesday, December 20th, 2017
  • Sumant Kulkarni of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $35 on, Friday, October 27th, 2017
  • Stanley Elliott of "Stifel" Maintained at Strong Buy with Increased Target to $31 on, Monday, October 23rd, 2017